| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hildebrand Ryan Jason | Chief Innovation Officer | C/O BANKWELL FINANCIAL GROUP, INC., 258 ELM STREET, NEW CANAAN | /s/ Angelo G. Fusaro, Attorney-in-Fact for Ryan J. Hildebrand | 2025-08-05 | 0001982685 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BWFG | Common Stock | Sale | -$81.4K | -2.05K | -100% | $39.69 | 0 | Aug 4, 2025 | Direct | |
| holding | BWFG | Common Stock | 15K | Aug 4, 2025 | Direct | F1 | |||||
| holding | BWFG | Common Stock | 3.33K | Aug 4, 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | 15,000 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. These shares are performance restricted stock with a three year cliff vesting on February 7, 2028 if the performance goals are achieved. |
| F2 | 10,000 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. The shares are restricted stock that will vest in three substantially equal annual installments, with the first installment vested on July 1, 2024 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. As of the filing date, 6,666 shares have vested. |